Citadel Advisors’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-827
Closed -$20K 15247
2021
Q3
$20K Sell
827
-40
-5% -$1.2K ﹤0.01% 13641
2021
Q2
$30K Sell
867
-1,266
-59% -$50.3K ﹤0.01% 13483
2021
Q1
$103K Buy
2,133
+426
+25% +$24.7K ﹤0.01% 12454
2020
Q4
$83K Buy
+1,707
New +$64.2K ﹤0.01% 10332

Other funds holding NH

Citadel Advisors's NH Position: Q4 2022 in Review

Citadel Advisors sold out of NantHealth, Inc (NH) in Q4 2022, closing a stake of 3,197 shares — an estimated $12K sold.

Citadel Advisors first reported a position in NH in Q1 2017 and held it in 14 quarters. The position peaked at $152K in Q1 2021. 18 funds tracked by Wall St. Rank hold NH as of Q4 2022.

  • Citadel Advisors reported no remaining NantHealth, Inc position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 3,197 NantHealth, Inc shares in Q4 2022, an estimated $12K.
  • Citadel Advisors first reported a position in NantHealth, Inc in Q1 2017 and held it in 14 quarters.
  • Citadel Advisors's NantHealth, Inc position peaked at $152K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.